Biotargeted Nanomedicines for Cancer: Six Tenets Before You Begin
Authors:
- 8 February 2013
- journal article
- Published by Taylor & Francis in Nanomedicine
- Vol. 8 (2) , 299-308
Abstract
Biotargeted nanomedicines have captured the attention of academic and industrial scientists who have been motivated by the theoretical possibilities of the ‘magic bullet’ that was first conceptualized by Paul Ehrlich at the beginning of the 20th century. The Biotargeting Working Group, consisting of more than 50 pharmaceutical scientists, engineers, biologists and clinicians, has been formed as part of the National Cancer Institute’s Alliance for Nanotechnology in Cancer to harness collective wisdom in order to tackle conceptual and practical challenges in developing biotargeted nanomedicines for cancer. In modern science and medicine, it is impossible for any individual to be an expert in every aspect of biology, chemistry, materials science, pharmaceutics, toxicology, chemical engineering, imaging, physiology, oncology and regulatory affairs. Drawing on the expertise of leaders from each of these disciplines, this commentary highlights six tenets of biotargeted cancer nanomedicines in order to enable th...Keywords
This publication has 58 references indexed in Scilit:
- More Effective Nanomedicines through Particle DesignSmall, 2011
- Multi-stage delivery nano-particle systems for therapeutic applicationsBiochimica et Biophysica Acta (BBA) - General Subjects, 2011
- Intracellular Trafficking Considerations in the Development of Natural Ligand-Drug Molecular Conjugates for CancerAnnals of Biomedical Engineering, 2011
- Synthesis of Size‐Tunable Polymeric Nanoparticles Enabled by 3D Hydrodynamic Flow Focusing in Single‐Layer MicrochannelsAdvanced Materials, 2011
- A Light‐Activated Theranostic Nanoagent for Targeted Macrophage Ablation in Inflammatory AtherosclerosisSmall, 2010
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- A unified mathematical model for the prediction of controlled release from surface and bulk eroding polymer matricesBiomaterials, 2009
- Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in vivo Tumor Targeting and ImagingSmall, 2009
- HER‐2‐Targeted Nanoparticle–Affibody Bioconjugates for Cancer TherapyChemMedChem, 2008
- Protease‐Triggered Unveiling of Bioactive NanoparticlesSmall, 2008